Adaptimmune Therapeutics plc - ADR logo

Adaptimmune Therapeutics plc - ADR (ADAPY)

Market Closed
14 Aug, 20:00
OTC PINK OTC PINK
$
0. 03
+0
+7.4074%
$
- Market Cap
- P/E Ratio
- Div Yield
104,600 Volume
-0.44 Eps
$ 0.03
Previous Close
Add Transaction
Day Range
0.02 0.03
Year Range
0 0.28
Want to track ADAPY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Adaptimmune Therapeutics plc - ADR logo
ADAPY Adaptimmune Therapeutics plc - ADR
20 May 2026
-
-
Adaptimmune Therapeutics plc - ADR logo
ADAPY Adaptimmune Therapeutics plc - ADR
18 Mar 2026
-
-

ADAPY Earnings Reports FAQ

What is the earnings per share (EPS) for ADAPY?

The current EPS is -0.44.

What is the company's earnings growth rate?

Adaptimmune Therapeutics plc - ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Adaptimmune Therapeutics plc - ADR has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Adaptimmune Therapeutics plc - ADR are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ADAPY at this time, as Adaptimmune Therapeutics plc - ADR has no recent EPS data to calculate it.